GD3 Synthase Overexpression Sensitizes Hepatocarcinoma Cells to Hypoxia and Reduces Tumor Growth by Suppressing the cSrc/NF-κB Survival Pathway
Open Access
- 26 November 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (11) , e8059
Abstract
Hypoxia-mediated HIF-1α stabilization and NF-κB activation play a key role in carcinogenesis by fostering cancer cell survival, angiogenesis and tumor invasion. Gangliosides are integral components of biological membranes with an increasingly recognized role as signaling intermediates. In particular, ganglioside GD3 has been characterized as a proapoptotic lipid effector by promoting cell death signaling and suppression of survival pathways. Thus, our aim was to analyze the role of GD3 in hypoxia susceptibility of hepatocarcinoma cells and in vivo tumor growth. We generated and characterized a human hepatocarcinoma cell line stably expressing GD3 synthase (Hep3B-GD3), which catalyzes the synthesis of GD3 from GM3. Despite increased GD3 levels (2–3 fold), no significant changes in cell morphology or growth were observed in Hep3B-GD3 cells compared to wild type Hep3B cells under normoxia. However, exposure of Hep3B-GD3 cells to hypoxia (2% O2) enhanced reactive oxygen species (ROS) generation, resulting in decreased cell survival, with similar findings observed in Hep3B cells exposed to increasing doses of exogenous GD3. In addition, hypoxia-induced c-Src phosphorylation at tyrosine residues, NF-κB activation and subsequent expression of Mn-SOD were observed in Hep3B cells but not in Hep3B-GD3 cells. Moreover, MnTBAP, an antioxidant with predominant SOD mimetic activity, reduced ROS generation, protecting Hep3B-GD3 cells from hypoxia-induced death. Finally, lower tumor growth, higher cell death and reduced Mn-SOD expression were observed in Hep3B-GD3 compared to Hep3B tumor xenografts. These findings underscore a role for GD3 in hypoxia susceptibility by disabling the c-Src/NF-κB survival pathway resulting in lower Mn-SOD expression, which may be of relevance in hepatocellular carcinoma therapy.Keywords
This publication has 43 references indexed in Scilit:
- Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancerJournal of Cancer Research and Clinical Oncology, 2009
- Acetylation Suppresses the Proapoptotic Activity of GD3 GangliosideJournal of Experimental Medicine, 2002
- Orally administered pimonidazole to label hypoxic tumor cells.2002
- Ganglioside GD3 Sensitizes Human Hepatoma Cells to Cancer TherapyJournal of Biological Chemistry, 2002
- Ganglioside Modulation Regulates Epithelial Cell Adhesion and Spreading via Ganglioside-specific Effects on SignalingJournal of Biological Chemistry, 2002
- Trafficking of Ganglioside GD3 to Mitochondria by Tumor Necrosis Factor-αJournal of Biological Chemistry, 2002
- Immunoseparation of sphingolipid‐enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG‐1 by anti‐GD3 ganglioside monoclonal antibodyJournal of Neurochemistry, 2001
- Ganglioside GD3 enhances apoptosis by suppressing the nuclear factor-κB-dependent survival pathwayThe FASEB Journal, 2001
- GD3 ganglioside directly targets mitochondria in a bcl‐2‐controlled fashionThe FASEB Journal, 2000
- Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.1999